BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34897474)

  • 1. Noninvasive Prenatal Diagnosis of a Paternally Inherited MEN1 Pathogenic Splicing Variant.
    Huby T; Le Guillou E; Burin des Roziers C; Pacot L; Briand-Suleau A; Chansavang A; Toussaint A; Duchossoy V; Vaucouleur N; Benoit V; Lodé L; Molac C; North MO; Grotto S; Tsatsaris V; Jouinot A; Cochand-Priollet B; Paepegaey AC; Nectoux J; Groussin L; Pasmant E
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1367-e1373. PubMed ID: 34897474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p.Ala541Thr variant of MEN1 gene: a non deleterious polymorphism or a pathogenic mutation?
    Nozières C; Zhang CX; Buffet A; Dupasquier S; Vargas-Poussou R; Guillaud-Bataille M; Cordier-Bussat M; Ruszniewski P; Christin-Maitre S; Murat A; Groussin L; Vezzosi D; Cardot-Bauters C; Hervieu V; Joly MO; Giraud S; Odou MF; Gimenez-Roqueplo AP; Goudet P; Borson-Chazot F; Calender A;
    Ann Endocrinol (Paris); 2014 Jul; 75(3):133-40. PubMed ID: 24997771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas.
    Smirne C; Giacomini GM; Berton AM; Pasini B; Mercalli F; Prodam F; Caputo M; Brosens LAA; Mollero ELM; Pitino R; Pirisi M; Aimaretti G; Ghigo E
    J Endocrinol Invest; 2024 Jul; 47(7):1815-1825. PubMed ID: 38294658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The uncertainty of copy number variants: pregnancy decisions and clinical follow-up.
    Shi P; Liang H; Hou Y; Chen D; Ren H; Wang C; Xia Y; Zhang D; Leigh D; Cram DS; Kong X
    Am J Obstet Gynecol; 2023 Aug; 229(2):170.e1-170.e8. PubMed ID: 36716986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism.
    Pannett AA; Kennedy AM; Turner JJ; Forbes SA; Cavaco BM; Bassett JH; Cianferotti L; Harding B; Shine B; Flinter F; Maidment CG; Trembath R; Thakker RV
    Clin Endocrinol (Oxf); 2003 May; 58(5):639-46. PubMed ID: 12699448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of the Clinical Presentation of the MEN1 LRG_509 c.781C>T (p.Leu261Phe) Variant Within a Three-Generation Family.
    Gilis-Januszewska A; Bogusławska A; Hasse-Lazar K; Jurecka-Lubieniecka B; Jarząb B; Sowa-Staszczak A; Opalińska M; Godlewska M; Grochowska A; Skalniak A; Hubalewska-Dydejczyk A
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33807230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UMD-MEN1 Database: An Overview of the 370 MEN1 Variants Present in 1676 Patients From the French Population.
    Romanet P; Mohamed A; Giraud S; Odou MF; North MO; Pertuit M; Pasmant E; Coppin L; Guien C; Calender A; Borson-Chazot F; Béroud C; Goudet P; Barlier A
    J Clin Endocrinol Metab; 2019 Mar; 104(3):753-764. PubMed ID: 30339208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline mutation of the multiple endocrine neoplasia type 1 (MEN1) gene in a family with primary hyperparathyroidism.
    Ohye H; Sato M; Matsubara S; Miyauchi A; Imachi H; Murao K; Takahara J
    Endocr J; 1998 Dec; 45(6):719-23. PubMed ID: 10395226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism.
    Cetani F; Pardi E; Giovannetti A; Vignali E; Borsari S; Golia F; Cianferotti L; Viacava P; Miccoli P; Gasperi M; Pinchera A; Marcocci C
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):457-64. PubMed ID: 11966738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism.
    Teh BT; Kytölä S; Farnebo F; Bergman L; Wong FK; Weber G; Hayward N; Larsson C; Skogseid B; Beckers A; Phelan C; Edwards M; Epstein M; Alford F; Hurley D; Grimmond S; Silins G; Walters M; Stewart C; Cardinal J; Khodaei S; Parente F; Tranebjaerg L; Jorde R; Salmela P
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2621-6. PubMed ID: 9709921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive genetic screening and clinical findings in multiple endocrine neoplasia type I families.
    Kopp I; Bartsch D; Wild A; Schilling T; Nies C; Bergenfelz A; Rieder H; Simon B; Rothmund M
    World J Surg; 2001 May; 25(5):610-6. PubMed ID: 11369988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region.
    Karges W; Jostarndt K; Maier S; Flemming A; Weitz M; Wissmann A; Feldmann B; Dralle H; Wagner P; Boehm BO
    J Endocrinol; 2000 Jul; 166(1):1-9. PubMed ID: 10856877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of an intracellular stability test of a novel missense menin mutant to the diagnosis of multiple endocrine neoplasia type 1.
    Nagamura Y; Yamazaki M; Shimazu S; Tsukada T; Sakurai A
    Endocr J; 2012; 59(12):1093-8. PubMed ID: 22878668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
    Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole genome sequencing of apparently mutation-negative MEN1 patients.
    Backman S; Bajic D; Crona J; Hellman P; Skogseid B; Stålberg P
    Eur J Endocrinol; 2020 Jan; 182(1):35-45. PubMed ID: 31658439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.
    Frank-Raue K; Rondot S; Hoeppner W; Goretzki P; Raue F; Meng W
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4063-7. PubMed ID: 15870131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel germline mutation of multiple endocrine neoplasia type 1 (MEN1) gene in a Japanese MEN1 patient and her daughter.
    Ohye H; Sato M; Matsubara S; Miyauchi A; Kishi-Imai K; Murao K; Takahara J
    Endocr J; 1999 Apr; 46(2):325-9. PubMed ID: 10460018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial isolated primary hyperparathyroidism--a multiple endocrine neoplasia type 1 variant?
    Miedlich S; Lohmann T; Schneyer U; Lamesch P; Paschke R
    Eur J Endocrinol; 2001 Aug; 145(2):155-60. PubMed ID: 11454510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEN1 gene analysis in patients with primary hyperparathyroidism: 10-year experience of a single institution for thyroid and parathyroid care in Japan.
    Kihara M; Miyauchi A; Ito Y; Yoshida H; Miya A; Kobayashi K; Takamura Y; Fukushima M; Inoue H; Higashiyama T; Tomoda C
    Endocr J; 2009; 56(5):649-56. PubMed ID: 19461164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.
    Agarwal SK; Kester MB; Debelenko LV; Heppner C; Emmert-Buck MR; Skarulis MC; Doppman JL; Kim YS; Lubensky IA; Zhuang Z; Green JS; Guru SC; Manickam P; Olufemi SE; Liotta LA; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
    Hum Mol Genet; 1997 Jul; 6(7):1169-75. PubMed ID: 9215689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.